Investment manager Laura Faulconer says technologies should be a positive experience for patients
Technologies should align with the practice’s vision, and suit the team’s level of acceptance of change and capability for preparing for and managing , Letitia O'Dwyer, Letitia O’Dwyer, Asthma and Respiratory Foundation NZ chief executive, advises general practices to take note of NGOs that may be able to help them
Your patient with type 2 diabetes is not reaching HbA1c target after lifestyle changes and treatment with metformin. So what next? Dr Rick Cutfield takes an expert look at the second-line treatment options available in New Zealand, including newly funded DPP-4 inhibitor vildagliptin.